# OnCo record mst-0312 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mst-0312/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mst-0312" ;
  schema:name "MST-0312"@en ;
  schema:description "MST-0312 is an experimental bispecific agonist antibody from Mestag Therapeutics, in phase 1 trials for advanced solid tumours."@en ;
  schema:url <https://onco.cc/drugs/mst-0312/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://svhealthinvestors.com/news/mestag-therapeutics-announces-the-first-patient-dosed-with-mst-0312-in-the-phase-i-starlys-trial>, <https://clinicaltrials.gov/study/NCT07610941>, <https://clinicaltrials.gov/search?intr=MST-0312> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Bispecific agonist antibody" ;
  onco:targets <https://onco.cc/targets/fap/> ;
  onco:companies <https://onco.cc/companies/mestag-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07610941/> .